The Cooper Companies, Inc. (0I3I)
LSE
Closed
Aug 25, 2026
Day's Range
73.7252 wk Range
57.64Overview - 0I3I - The Cooper Companies, Inc.
Key Statistics
Valuation
Enterprise Value
17.41B
P/E (Trailing)
‪0.03‬
Price / Book
‪1.79‬
EV / EBITDA
‪19.65‬
Profitability
Profit Margin
‪5.57%‬
Operating Margin
‪-2.86%‬
Return on Assets
‪2.51%‬
Return on Equity
‪2.85%‬
Ownership
Shares Outstanding
49.13M
Float
193.67M
Held by Insiders
‪0.61%‬
Held by Institutions
‪109.22%‬
Price stats
Beta
‪0.82‬
50-Day Avg
‪95.76‬
200-Day Avg
‪90.81‬
Dividends
Frequency
Semi-Annual
Market Cap - 0I3I - The Cooper Companies, Inc.
Peers - 0I3I - The Cooper Companies, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on LSE.
Profile Summary - 0I3I - The Cooper Companies, Inc.
About
The Cooper Companies, Inc. is a global medical device company operating through two primary segments: CooperVision and CooperSurgical. CooperVision specializes in vision care, offering a comprehensive portfolio of contact lenses including spherical, multifocal, toric, and specialty lenses under brands such as…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
